Robert Rabalais, MD
Orthopaedic Surgery · Baton Rouge, LANPI 1083630040
Payments from drug & device makers
Across 126 payments — averaging $43.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ALON Medical Technology$2K
- Arthrex$2K
- Amgen$601
- Smith+Nephew$292
- Ferring Pharmaceuticals Inc.$214
- Innovation Technologies Inc$170
- plus $997 from 11 others
What the payments were for
- Travel & lodging$2,74650%
- Food & beverage$2,70349%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ALON Medical Technology | 6 | $1,607 |
| Arthrex | 29 | $1,589 |
| Amgen | 49 | $601 |
| Smith+Nephew | 5 | $292 |
| Ferring Pharmaceuticals Inc. | 12 | $214 |
| Innovation Technologies Inc | 1 | $170 |
| Pacira Pharmaceuticals Incorporated | 4 | $151 |
| Stryker | 3 | $151 |
| Vericel Corporation | 3 | $142 |
| Biorez, Inc. | 1 | $120 |
| Organogenesis Inc. | 1 | $110 |
| Pacira Therapeutics, Inc. | 5 | $90 |
| Henry Schein, Inc. | 1 | $78 |
| Medtronic | 2 | $54 |
| Boston Scientific | 1 | $53 |
| Bioventus LLC | 2 | $34 |
| Sanara Medtech Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,471 in reported general payments places this provider in the 55th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 441 | $1,380 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 123 | $802 |
| Ondansetron OdtOndansetron | 42 | $525 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 54 | $474 |
| Naproxen | 62 | $406 |
| Celecoxib | 32 | $356 |
| Ibuprofen | 25 | $226 |
| Tramadol Hcl | 95 | $224 |
| Methylprednisolone | 26 | $192 |
| Promethazine Hcl | 44 | $169 |
| Cyclobenzaprine Hcl | 17 | $137 |
| Clindamycin Hcl | 13 | $105 |
| Pregabalin | 12 | $61 |
| Amoxicillin | 28 | $35 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $21 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Baton Rouge
- Christopher HarrodBaton Rouge$3.1M
- Jorge IsazaBaton Rouge$1.2M
- Kevin McCarthyBaton Rouge$714K
- Robert EastonBaton Rouge$394K
- Ricardo RodriguezBaton Rouge$262K
- Wame WaggenspackBaton Rouge$82K
- Shaun AccardoBaton Rouge$52K
- Kevin RicheBaton Rouge$33K
- William ShermanBaton Rouge$29K
- David FerachiBaton Rouge$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.